Back to Search
DONALD COVELL, M.D.
M.D.
Orthopaedic Surgery Physician
NPI: 1124346002IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
R2444(KY)2015-00799(NC)
Education
UNIVERSITY OF KENTUCKY COLLEGE OF MEDICINE
Class of 2010
Research & Publications (20)
Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri.
PMID 19061394·Org Lett·2009
8-other
Plaque retention by self-ligating vs elastomeric orthodontic brackets: quantitative comparison of oral bacteria and detection with adenosine triphosphate-driven bioluminescence.
PMID 19361723·Am J Orthod Dentofacial Orthop·2009
2-rct
Enantioselective synthesis of (+)-chamaecypanone C: a novel microtubule inhibitor.
PMID 19140149·Angew Chem Int Ed Engl·2009
7-preclinical
A chiral Lewis acid strategy for enantioselective allylic C-H oxidation.
PMID 18624317·Angew Chem Int Ed Engl·2008
8-other
Connecting chemosensitivity, gene expression and disease.
PMID 18055024·Trends Pharmacol Sci·2008
8-other
Patterns of dental care utilization among patients with temporomandibular disorders.
PMID 18548839·J Orofac Pain·2008
8-other
Human experience seeking correlates with hippocampus volume: convergent evidence from manual tracing and voxel-based morphometry.
PMID 17603086·Neuropsychologia·2007
8-other
Three cements used for orthodontic banding of porcelain molars.
PMID 17029542·Angle Orthod·2007
4-observational
Data mining of NCI's anticancer screening database reveals mitochondrial complex I inhibitors cytotoxic to leukemia cell lines.
PMID 17109823·Biochem Pharmacol·2007
7-preclinical
Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening data.
PMID 17699723·Mol Cancer Ther·2007
8-other
Differential gene expression as a potential classifier of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole-sensitive and -insensitive cell lines.
PMID 16332985·Mol Pharmacol·2006
8-other
Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen.
PMID 16386875·Genomics·2006
8-other
Assessment of in vitro and in vivo activities in the National Cancer Institute's anticancer screen with respect to chemical structure, target specificity, and mechanism of action.
PMID 16539384·J Med Chem·2006
8-other
Polyol synthesis through hydrocarbon oxidation: de novo synthesis of L-galactose.
PMID 17109456·Angew Chem Int Ed Engl·2006
8-other
Targeting changes in cancer: assessing pathway stability by comparing pathway gene expression coherence levels in tumor and normal tissues.
PMID 16985076·Mol Cancer Ther·2006
8-other
Anticancer metal compounds in NCI's tumor-screening database: putative mode of action.
PMID 15763539·Biochem Pharmacol·2005
6-review
Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases.
PMID 15778971·Proteins·2005
6-review
Drugs aimed at targeting characteristic karyotypic phenotypes of cancer cells.
PMID 16227406·Mol Cancer Ther·2005
8-other
Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.
PMID 16103895·Pharmacogenomics J·2005
4-observational
Cytotoxicity of RH1: NAD(P)H:quinone acceptor oxidoreductase (NQO1)-independent oxidative stress and apoptosis induction.
PMID 15746574·Anticancer Drugs·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 333 S 3RD ST, SUITE B
DANVILLE, KY 40422 - Phone
- (859) 236-8730
Quick Facts
- NPI
- 1124346002
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile